NIH-funded research NIH-funded research

Creating a biorepository for cancer prevention samples.

Official title: DCP - Cancer Prevention Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia) BioRepository

Funded at Leidos Biomedical Research, INC. · NIH-11219788 · Data updated 2026-11-12

This study is creating a collection of biological samples from patients to help researchers find better ways to prevent cancer, and you might have the chance to contribute your samples to support this important work.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionLeidos Biomedical Research, INC.
NIH-funded
Lab location1 site (Frederick, United States)
Project startSeptember 28, 2024
Project endAugust 30, 2025
Funding year2024
Award (this year)$25,663
NIH project number75N91019D00024-0-759102400011-20
Project IDNIH-11219788 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation include individuals who are at risk for cancer and willing to provide biological samples for research purposes.

Less likely to help

Patients who are not at risk for cancer or those who do not wish to participate in providing biological samples may not benefit from this research.

What this research studies

This research aims to establish a biorepository that collects and stores biological specimens from clinical sites contracted by the Division of Cancer Prevention (DCP). By gathering these samples, the project will facilitate future cancer prevention clinical trials and research. Patients may have the opportunity to contribute their biological samples, which can be used to advance understanding and strategies in cancer prevention. The biorepository will serve as a valuable resource for researchers looking to develop new preventive measures against cancer.

Why it matters

Potential benefit: If successful, this research could enhance cancer prevention strategies and lead to improved outcomes for individuals at risk of developing cancer.

How similar studies have gone: Other research initiatives have successfully established biorepositories, demonstrating their value in advancing cancer prevention and treatment research.

Where this research is happening

  • Leidos Biomedical Research, INC.
    Frederick, United States
    Active

Researchers

  • Principal investigator: Briscoe, Lynn — Leidos Biomedical Research, INC.
  • Study coordinator: Briscoe, Lynn

Related research

Other NIH-funded projects on the same topics.

  • Improving public health responses to COVID-19 through standardized testing.

    This study is looking to improve how we fight COVID-19 by testing blood samples to see if people have had the virus, and it’s designed for anyone interested in better ways to manage the disease.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11220317

  • Creating a large library of cancer models for research use

    This study is creating a collection of new cancer models to help researchers and companies find better ways to treat cancer, making it easier for everyone to work together and share ideas.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11219823

  • Advancing global cancer control through data analysis and international collaboration

    This study is all about helping countries around the world work better together to fight cancer by sharing important information and training scientists, especially in places that need extra support.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11219804

  • Support for HIV and HPV cancer prevention clinical trials in the Americas

    This study is working on new vaccines and treatments to help prevent cancers related to HIV and HPV, making sure that patients in the US, Latin America, and the Caribbean can access better options as these exciting trials move forward.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11219802

  • Development and production of clinical-grade biopharmaceuticals

    This study is all about making safe and effective new medicines, like vaccines and treatments for various conditions, so that patients can have access to the latest therapies that meet high-quality standards.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11219801

  • Understanding the immune response to COVID-19

    This study is looking for ways to improve COVID-19 testing and understand how our immune system fights the virus, and you can help by sharing samples to make these tests better for everyone.

    NIH research Leidos Biomedical Research, INC. · Frederick, United States · NIH-11219800

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.